NB017977
VEGF-C Antibody (MM0006-2E65) - Azide and BSA Free, Novus Biologicals™
Manufacturer: Fischer Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | NB017977-Each-of-1 | In Stock | ₹ 17,668.14 |
NB017977 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 17,668.14
GST (18%): ₹ 3,180.265
Total Price: ₹ 20,848.405
Antigen
VEGF-C
Classification
Monoclonal
Concentration
LYOPH
Dilution
Western Blot 1:1000, Immunohistochemistry 1:25-50, Immunohistochemistry-Paraffin 1:25-1:50
Gene Accession No.
P49767
Gene Symbols
VEGFC
Immunogen
This antibody was produced from a hybridoma (mouse myeloma fused with spleen cells) from a mouse immunized with recombinant human VEGF-C recombinant protein.
Quantity
0.025 mg
Research Discipline
Angiogenesis, Cancer
Gene ID (Entrez)
7424
Reconstitution
Reconstitute with 0.5 ml sterilized PBS to a final concentration of 0.2 mg/ml.
Content And Storage
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
Isotype
IgG2
Applications
Western Blot, Immunohistochemistry (Paraffin), Immunohistochemistry
Clone
MM0006-2E65
Conjugate
Unconjugated
Formulation
A 0.2 um filtered solution in PBS with No Preservative
Gene Alias
Flt4 ligand, Flt4-L, vascular endothelial growth factor C, Vascular endothelial growth factor-related protein, VEGF-C, VRPFLT4 ligand DHM
Host Species
Mouse
Purification Method
Protein G purified
Regulatory Status
RUO
Primary or Secondary
Primary
Test Specificity
No cross-reactivity is shown with human VEGFA, VEGF-B and VEGF-D.
Target Species
Human
Form
Purified
Description
- VEGF-C Monoclonal specifically detects VEGF-C in Human samples
- It is validated for Western Blot, Immunohistochemistry, Immunohistochemistry-Paraffin.
Compare Similar Items
Show Difference
Antigen: VEGF-C
Classification: Monoclonal
Concentration: LYOPH
Dilution: Western Blot 1:1000, Immunohistochemistry 1:25-50, Immunohistochemistry-Paraffin 1:25-1:50
Gene Accession No.: P49767
Gene Symbols: VEGFC
Immunogen: This antibody was produced from a hybridoma (mouse myeloma fused with spleen cells) from a mouse immunized with recombinant human VEGF-C recombinant protein.
Quantity: 0.025 mg
Research Discipline: Angiogenesis, Cancer
Gene ID (Entrez): 7424
Reconstitution: Reconstitute with 0.5 ml sterilized PBS to a final concentration of 0.2 mg/ml.
Content And Storage: Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
Isotype: IgG2
Applications: Western Blot, Immunohistochemistry (Paraffin), Immunohistochemistry
Clone: MM0006-2E65
Conjugate: Unconjugated
Formulation: A 0.2 um filtered solution in PBS with No Preservative
Gene Alias: Flt4 ligand, Flt4-L, vascular endothelial growth factor C, Vascular endothelial growth factor-related protein, VEGF-C, VRPFLT4 ligand DHM
Host Species: Mouse
Purification Method: Protein G purified
Regulatory Status: RUO
Primary or Secondary: Primary
Test Specificity: No cross-reactivity is shown with human VEGFA, VEGF-B and VEGF-D.
Target Species: Human
Form: Purified
Antigen:
VEGF-C
Classification:
Monoclonal
Concentration:
LYOPH
Dilution:
Western Blot 1:1000, Immunohistochemistry 1:25-50, Immunohistochemistry-Paraffin 1:25-1:50
Gene Accession No.:
P49767
Gene Symbols:
VEGFC
Immunogen:
This antibody was produced from a hybridoma (mouse myeloma fused with spleen cells) from a mouse immunized with recombinant human VEGF-C recombinant protein.
Quantity:
0.025 mg
Research Discipline:
Angiogenesis, Cancer
Gene ID (Entrez):
7424
Reconstitution:
Reconstitute with 0.5 ml sterilized PBS to a final concentration of 0.2 mg/ml.
Content And Storage:
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
Isotype:
IgG2
Applications:
Western Blot, Immunohistochemistry (Paraffin), Immunohistochemistry
Clone:
MM0006-2E65
Conjugate:
Unconjugated
Formulation:
A 0.2 um filtered solution in PBS with No Preservative
Gene Alias:
Flt4 ligand, Flt4-L, vascular endothelial growth factor C, Vascular endothelial growth factor-related protein, VEGF-C, VRPFLT4 ligand DHM
Host Species:
Mouse
Purification Method:
Protein G purified
Regulatory Status:
RUO
Primary or Secondary:
Primary
Test Specificity:
No cross-reactivity is shown with human VEGFA, VEGF-B and VEGF-D.
Target Species:
Human
Form:
Purified
Antigen: PDGF-B
Classification: Monoclonal
Concentration: LYOPH
Dilution: Western Blot 1:1000, Flow Cytometry 1:10-1:1000, Immunohistochemistry 1:50-1:200, Immunohistochemistry-Paraffin 1:50-1:200, CyTOF-ready
Gene Accession No.: P01127
Gene Symbols: PDGFB
Immunogen: This antibody was produced from a hybridoma (mouse myeloma fused with spleen cells from a mouse immunized with human PDGF BB recombinant protein.
Quantity: 0.025 mg
Research Discipline: Cell Cycle and Replication
Gene ID (Entrez): 5155
Reconstitution: Reconstitute with 0.5 ml sterilized PBS to a final concentration of 0.2 mg/ml.
Content And Storage: Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
Isotype: IgG1
Applications: CyTOF, Flow Cytometry, Immunohistochemistry, Western Blot, Immunohistochemistry (Paraffin)
Clone: MM0014-5F66
Conjugate: Unconjugated
Formulation: A 0.2 um filtered solution in PBS with No Preservative
Gene Alias: B chain, Becaplermin, FLJ12858, PDGF subunit B, PDGF2, PDGF-2, platelet-derived growth factor 2, Platelet-derived growth factor beta polypeptide, platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis)oncogene homolog), platelet-derived growth factor subunit B, platelet-derived growth factor, B chain, Platelet-derived growth factor, beta polypeptide (oncogene SIS), Proto-oncogene c-Sis, SSV
Host Species: Mouse
Purification Method: Protein G purified
Regulatory Status: RUO
Primary or Secondary: Primary
Test Specificity: This antibody shows approximately some degree (40%) cross-reactivity with rPDGF-AB and no cross-reactivity with recombinant PDGF-AA.
Target Species: Human
Form: Purified
Antigen:
PDGF-B
Classification:
Monoclonal
Concentration:
LYOPH
Dilution:
Western Blot 1:1000, Flow Cytometry 1:10-1:1000, Immunohistochemistry 1:50-1:200, Immunohistochemistry-Paraffin 1:50-1:200, CyTOF-ready
Gene Accession No.:
P01127
Gene Symbols:
PDGFB
Immunogen:
This antibody was produced from a hybridoma (mouse myeloma fused with spleen cells from a mouse immunized with human PDGF BB recombinant protein.
Quantity:
0.025 mg
Research Discipline:
Cell Cycle and Replication
Gene ID (Entrez):
5155
Reconstitution:
Reconstitute with 0.5 ml sterilized PBS to a final concentration of 0.2 mg/ml.
Content And Storage:
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
Isotype:
IgG1
Applications:
CyTOF, Flow Cytometry, Immunohistochemistry, Western Blot, Immunohistochemistry (Paraffin)
Clone:
MM0014-5F66
Conjugate:
Unconjugated
Formulation:
A 0.2 um filtered solution in PBS with No Preservative
Gene Alias:
B chain, Becaplermin, FLJ12858, PDGF subunit B, PDGF2, PDGF-2, platelet-derived growth factor 2, Platelet-derived growth factor beta polypeptide, platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis)oncogene homolog), platelet-derived growth factor subunit B, platelet-derived growth factor, B chain, Platelet-derived growth factor, beta polypeptide (oncogene SIS), Proto-oncogene c-Sis, SSV
Host Species:
Mouse
Purification Method:
Protein G purified
Regulatory Status:
RUO
Primary or Secondary:
Primary
Test Specificity:
This antibody shows approximately some degree (40%) cross-reactivity with rPDGF-AB and no cross-reactivity with recombinant PDGF-AA.
Target Species:
Human
Form:
Purified
Antigen: Tie-2
Classification: Monoclonal
Concentration: LYOPH
Dilution: Western Blot 1:500 - 1:1000, ELISA 1:200 - 1:400, Immunohistochemistry 1:50, Immunohistochemistry-Paraffin 1:50
Gene Accession No.: Q02763
Gene Symbols: TEK
Immunogen: This antibody was produced from a hybridoma (mouse myeloma fused with spleen cells from a mouse immunized with purified human extracellular domain of Tie2 fragment).
Quantity: 0.025 mg
Research Discipline: Angiogenesis, Cancer, Protein Kinase
Gene ID (Entrez): 7010
Reconstitution: Reconstitute with 0.5 ml sterilized PBS to a final concentration of 0.2 mg/ml.
Content And Storage: Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
Isotype: IgG1
Applications: Western Blot, Immunohistochemistry (Paraffin), ELISA, Immunohistochemistry
Clone: MM0018-21G7
Conjugate: Unconjugated
Formulation: Lyophilized from 0.2 um filtered solution in PBS with No Preservative
Gene Alias: angiopoietin-1 receptor, CD202B, CD202b antigen, EC 2.7.10, EC 2.7.10.1, hTIE2, p140 TEK, soluble TIE2 variant 1, soluble TIE2 variant 2, TEK tyrosine kinase, endothelial, TIE-2, TIE2CD202b, Tunica interna endothelial cell kinase, Tyrosine-protein kinase receptor TEK, Tyrosine-protein kinase receptor TIE-2, venous malformations, multiple cutaneous and mucosal, VMCM, VMCM1
Host Species: Mouse
Purification Method: Protein G purified
Regulatory Status: RUO
Primary or Secondary: Primary
Test Specificity: Recognizes human Tie2, no cross-reactivity with human Tie1.
Target Species: Human
Form: Purified
Antigen:
Tie-2
Classification:
Monoclonal
Concentration:
LYOPH
Dilution:
Western Blot 1:500 - 1:1000, ELISA 1:200 - 1:400, Immunohistochemistry 1:50, Immunohistochemistry-Paraffin 1:50
Gene Accession No.:
Q02763
Gene Symbols:
TEK
Immunogen:
This antibody was produced from a hybridoma (mouse myeloma fused with spleen cells from a mouse immunized with purified human extracellular domain of Tie2 fragment).
Quantity:
0.025 mg
Research Discipline:
Angiogenesis, Cancer, Protein Kinase
Gene ID (Entrez):
7010
Reconstitution:
Reconstitute with 0.5 ml sterilized PBS to a final concentration of 0.2 mg/ml.
Content And Storage:
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
Isotype:
IgG1
Applications:
Western Blot, Immunohistochemistry (Paraffin), ELISA, Immunohistochemistry
Clone:
MM0018-21G7
Conjugate:
Unconjugated
Formulation:
Lyophilized from 0.2 um filtered solution in PBS with No Preservative
Gene Alias:
angiopoietin-1 receptor, CD202B, CD202b antigen, EC 2.7.10, EC 2.7.10.1, hTIE2, p140 TEK, soluble TIE2 variant 1, soluble TIE2 variant 2, TEK tyrosine kinase, endothelial, TIE-2, TIE2CD202b, Tunica interna endothelial cell kinase, Tyrosine-protein kinase receptor TEK, Tyrosine-protein kinase receptor TIE-2, venous malformations, multiple cutaneous and mucosal, VMCM, VMCM1
Host Species:
Mouse
Purification Method:
Protein G purified
Regulatory Status:
RUO
Primary or Secondary:
Primary
Test Specificity:
Recognizes human Tie2, no cross-reactivity with human Tie1.
Target Species:
Human
Form:
Purified
Antigen: MMP-7
Classification: Monoclonal
Concentration: LYOPH
Dilution: Western Blot 1:500-1:2000, Immunohistochemistry 1:50-200, Immunohistochemistry-Paraffin 1:50-1:200
Gene Accession No.: P09237
Gene Symbols: MMP7
Immunogen: This antibody was produced from a hybridoma (mouse myeloma fused with spleen cells from a mouse immunized with purified human recombinant MMP-7).
Quantity: 0.025 mg
Research Discipline: Angiogenesis, Cancer, Cell Biology, Cytoskeleton Markers, Extracellular Matrix, Wnt Signaling Pathway
Gene ID (Entrez): 4316
Reconstitution: Reconstitute with 0.5 ml sterilized PBS to a final concentration of 0.2 mg/ml.
Content And Storage: Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
Isotype: IgG2
Applications: Immunohistochemistry (Paraffin), Immunohistochemistry, Western Blot
Clone: MM0022-4C21
Conjugate: Unconjugated
Formulation: A 0.2 um filtered solution in PBS with No Preservative
Gene Alias: EC 3.4.24, EC 3.4.24.23, matrilysin, matrin, matrix metallopeptidase 7 (matrilysin, uterine), matrix metalloproteinase 7 (matrilysin, uterine), Matrix metalloproteinase-7, MMP-7, MPSL1, PUMP1, PUMP-1, Pump-1 protease, uterine matrilysin, Uterine metalloproteinase
Host Species: Mouse
Purification Method: Protein G purified
Regulatory Status: RUO
Primary or Secondary: Primary
Test Specificity: MMP7 (MM0022-4C21). This antibody recognizes human MMP-7 in western blot without cross reactivity with other human MMPs.
Target Species: Human
Form: Purified
Antigen:
MMP-7
Classification:
Monoclonal
Concentration:
LYOPH
Dilution:
Western Blot 1:500-1:2000, Immunohistochemistry 1:50-200, Immunohistochemistry-Paraffin 1:50-1:200
Gene Accession No.:
P09237
Gene Symbols:
MMP7
Immunogen:
This antibody was produced from a hybridoma (mouse myeloma fused with spleen cells from a mouse immunized with purified human recombinant MMP-7).
Quantity:
0.025 mg
Research Discipline:
Angiogenesis, Cancer, Cell Biology, Cytoskeleton Markers, Extracellular Matrix, Wnt Signaling Pathway
Gene ID (Entrez):
4316
Reconstitution:
Reconstitute with 0.5 ml sterilized PBS to a final concentration of 0.2 mg/ml.
Content And Storage:
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
Isotype:
IgG2
Applications:
Immunohistochemistry (Paraffin), Immunohistochemistry, Western Blot
Clone:
MM0022-4C21
Conjugate:
Unconjugated
Formulation:
A 0.2 um filtered solution in PBS with No Preservative
Gene Alias:
EC 3.4.24, EC 3.4.24.23, matrilysin, matrin, matrix metallopeptidase 7 (matrilysin, uterine), matrix metalloproteinase 7 (matrilysin, uterine), Matrix metalloproteinase-7, MMP-7, MPSL1, PUMP1, PUMP-1, Pump-1 protease, uterine matrilysin, Uterine metalloproteinase
Host Species:
Mouse
Purification Method:
Protein G purified
Regulatory Status:
RUO
Primary or Secondary:
Primary
Test Specificity:
MMP7 (MM0022-4C21). This antibody recognizes human MMP-7 in western blot without cross reactivity with other human MMPs.
Target Species:
Human
Form:
Purified